SAPONARO, Giulia
 Distribuzione geografica
Continente #
EU - Europa 94
NA - Nord America 84
AS - Asia 28
AF - Africa 5
OC - Oceania 1
Totale 212
Nazione #
US - Stati Uniti d'America 82
IT - Italia 70
CN - Cina 12
FR - Francia 11
IN - India 5
DK - Danimarca 4
GB - Regno Unito 4
VN - Vietnam 3
CA - Canada 2
EG - Egitto 2
PL - Polonia 2
SG - Singapore 2
AE - Emirati Arabi Uniti 1
DE - Germania 1
DZ - Algeria 1
GR - Grecia 1
HK - Hong Kong 1
KR - Corea 1
MA - Marocco 1
MY - Malesia 1
NZ - Nuova Zelanda 1
RO - Romania 1
SA - Arabia Saudita 1
TR - Turchia 1
ZA - Sudafrica 1
Totale 212
Città #
Ferrara 50
Ashburn 12
Santa Cruz 6
Columbus 5
Houston 5
Shanghai 4
Boardman 3
Bologna 3
Dong Ket 3
Fairfield 3
Los Angeles 3
Pittsburgh 3
Seattle 3
Wilmington 3
Ann Arbor 2
Casette 2
Des Moines 2
Hartford 2
Southend 2
Tempe 2
Warsaw 2
Auburn 1
Auckland 1
Bedford 1
Beijing 1
Cairo 1
Cambridge 1
Casablanca 1
Cedar Knolls 1
Chapel Hill 1
Country Club Hills 1
Dallas 1
Dearborn 1
Este 1
Ferrara di Monte Baldo 1
Gebze 1
Ghaziabad 1
Giza 1
Grenoble 1
Gualdo 1
Hamilton 1
Hangzhou 1
Harbin 1
Hefei 1
Homewood 1
Hong Kong 1
Jaipur 1
Kansas City 1
Kongens Lyngby 1
Linyi 1
Lozzo Atestino 1
Mumbai 1
Nanchang 1
Nanjing 1
New York 1
Omaha 1
Padova 1
Palermo 1
Petaling Jaya 1
Piraeus 1
Pune 1
Roorkee 1
San Diego 1
Seongnam 1
Souk Ahras 1
Tarnaveni 1
Toronto 1
Washington 1
Xian 1
Totale 168
Nome #
Mortality from cancer in people with severe mental disorders in Emilia Romagna Region, Italy, file e309ade4-6f22-3969-e053-3a05fe0a2c94 63
Synthesis and Structure Activity Relationship Investigation of Triazolo[1,5-a]pyrimidines as CB2 Cannabinoid Receptor Inverse Agonists, file e309ade3-ff5f-3969-e053-3a05fe0a2c94 38
Design and Synthesis of New A2A and A3 Adenosine Receptors Antagonists, file e309ade1-d4bf-3969-e053-3a05fe0a2c94 37
Design, synthesis, and biological evaluation of novel 2-((2-(4-(substituted)phenylpiperazin-1-yl)ethyl)amino)-5'-N-ethylcarboxamidoadenosines as potent and selective agonists of the A2A adenosine receptor, file e309ade3-cfd0-3969-e053-3a05fe0a2c94 31
null, file e309ade0-cb9c-3969-e053-3a05fe0a2c94 8
One-pot reaction to obtain N,N'-disubstituted guanidines of pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidine scaffold as human A3 adenosine receptor antagonists, file e309ade0-7e5c-3969-e053-3a05fe0a2c94 5
7-Oxo-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxamides as Selective CB2 Cannabinoid Receptor Ligands: Structural Investigations around a Novel Class of Full Agonists, file e309ade0-ccd8-3969-e053-3a05fe0a2c94 5
A3 adenosine receptor antagonists: History and future perspectives, file e309ade1-88ae-3969-e053-3a05fe0a2c94 5
Design, synthesis, and biological evaluation of novel 2-((2-(4-(substituted)phenylpiperazin-1-yl)ethyl)amino)-5'-N-ethylcarboxamidoadenosines as potent and selective agonists of the A2A adenosine receptor, file e309ade0-cb8b-3969-e053-3a05fe0a2c94 4
7-Substituted-pyrrolo[3,2-d]pyrimidine-2,4-dione derivatives as antagonists of the transient receptor potential ankyrin 1 (TRPA1) channel: A promising approach for treating pain and inflammation, file e309ade0-cb90-3969-e053-3a05fe0a2c94 4
Synthesis and Structure Activity Relationship Investigation of Triazolo[1,5-a]pyrimidines as CB2 Cannabinoid Receptor Inverse Agonists, file e309ade1-151a-3969-e053-3a05fe0a2c94 4
Water-Soluble Pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidines as Human A3 Adenosine Receptor Antagonists, file e309ade0-2fe0-3969-e053-3a05fe0a2c94 3
null, file e309ade0-a439-3969-e053-3a05fe0a2c94 3
null, file e309ade1-2d29-3969-e053-3a05fe0a2c94 3
Synthesis and Biological Evaluation of Novel Allosteric Enhancers of the A1 Adenosine Receptor Based on 2-Amino-3-(4’-Chlorobenzoyl)-4-Substituted-5-Arylethynyl Thiophene, file e309ade0-415a-3969-e053-3a05fe0a2c94 2
Pyrazole phenylcyclohexylcarbamates as inhibitors of human fatty acid amide hydrolases (FAAH), file e309ade0-c408-3969-e053-3a05fe0a2c94 2
null, file e309ade0-c45d-3969-e053-3a05fe0a2c94 2
null, file e309ade0-ccae-3969-e053-3a05fe0a2c94 1
Totale 220
Categoria #
all - tutte 898
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 5
Totale 903


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202011 0 2 0 0 1 2 1 4 0 1 0 0
2020/202113 0 2 1 1 1 1 0 2 1 0 1 3
2021/202251 0 1 2 5 2 5 4 7 6 5 10 4
2022/202349 3 7 10 2 6 3 1 1 3 5 6 2
2023/202450 4 4 4 2 3 5 0 9 3 4 12 0
Totale 220